Tilray Brands to Announce Second Quarter Fiscal Year 2026 Financial Results on January 8, 2026
Rhea-AI Summary
Tilray Brands (Nasdaq: TLRY) will release second fiscal quarter results for the period ended November 30, 2025 after market close on Thursday, January 8, 2026.
The company will host a live conference call and audio webcast at 4:30 PM Eastern Time that day; the webcast will be available on the Events & Presentations section of Tilray’s investor relations website.
Investor Q&A will be open via Robinhood and Say Technologies beginning today through January 7, 2026, and questions can be submitted or upvoted on those platforms.
Positive
- None.
Negative
- None.
News Market Reaction 10 Alerts
On the day this news was published, TLRY declined 6.63%, reflecting a notable negative market reaction. Our momentum scanner triggered 10 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $90M from the company's valuation, bringing the market cap to $1.27B at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
TLRY fell 9.56% while closely scored peers showed small mixed moves (e.g., AMPH +0.76%, DVAX -0.18%, EVO -0.67%, HROW +3.92%, PCRX +2.13%), suggesting stock-specific pressure rather than a broad sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 18 | U.S. medical expansion | Positive | -4.2% | Launch of Tilray Medical USA following U.S. federal cannabis rescheduling. |
| Dec 11 | Product launch | Positive | +2.1% | Redecan Amped Live Resin Liquid Diamond vape line introduction in Canada. |
| Dec 04 | Marketing campaign | Positive | +2.6% | Release of Ultimate 2025 Holiday Drink Gift Guide across beverage brands. |
| Dec 04 | Marketing campaign | Positive | +2.6% | 2025 Cannabis Holiday Gift Guide highlighting leading Canadian cannabis SKUs. |
| Nov 26 | Capital structure change | Neutral | +4.8% | Implementation details of previously approved 1-for-10 reverse stock split. |
Recent product and expansion news with positive tone often saw positive 24h moves, while one major strategic expansion headline drew a negative reaction.
Over the past month, Tilray issued multiple brand and strategic updates. On Nov 26, 2025, it announced a 1-for-10 reverse stock split effective in early December, which preceded a 4.76% gain. Early December brought holiday drink and cannabis gift guides, each tied to +2.61% moves. A Redecan live resin vape launch on Dec 11 saw shares rise 2.06%. By contrast, the Dec 18, 2025 U.S. medical expansion announcement coincided with a -4.19% reaction. Today’s earnings-date notice fits within this ongoing cadence of brand and strategic communications.
Regulatory & Risk Context
An effective S-3ASR filed on Oct 9, 2025 includes a forward ATM program to offer up to $51,597,980 of common stock, register shares for warrant exercise, and enable resale by a selling stockholder, providing flexibility for future capital raises.
Market Pulse Summary
The stock moved -6.6% in the session following this news. A negative reaction despite a routine earnings-date announcement would fit a backdrop where TLRY previously saw a -4.19% move following a major U.S. medical expansion update, contrasted with gains on several marketing and branding releases. With shares already trading 51.9% below the 52-week high but above the 200-day average, investors might focus on whether prior capital structure changes and the existing shelf capacity increase perceived risk around future financing and earnings quality.
AI-generated analysis. Not financial advice.
NEW YORK and LEAMINGTON, Ontario, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage and wellness industries, today announced that the Company will release its financial results for the second fiscal quarter which ended November 30, 2025, after the financial markets close on Thursday, January 8, 2026.
Live Conference Call and Audio Webcast
Tilray will host a live conference call, which will be webcast, to discuss these results at 4:30 PM Eastern Time on the same day. The webcast can be accessed on the Events & Presentations section of Tilray’s Investor Relations website.
Investor Q&A
Investors can submit and upvote questions on Robinhood and Say Technologies, beginning today and until January 7, 2026. To submit questions ahead of the webcast, visit the Tilray stock detail page on Robinhood or the Say Technologies platform at app.saytechnologies.com/tilray-brands-2026-q2
About Tilray Brands
Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.
For more information on how we are elevating lives through moments of connection, visit Tilray.com and follow @Tilray on all social platforms.
Contacts:
Investor Relations
investors@tilray.com
Pro-TLRY@prosek.com
Media
news@tilray.com
FAQ
When will Tilray (TLRY) report its Q2 2026 financial results?
What period do Tilray's (TLRY) Q2 2026 results cover?
How can investors listen to Tilray's (TLRY) Q2 2026 earnings call?
How can investors submit questions for Tilray's (TLRY) January 8, 2026 call?
Where is the Say Technologies question submission link for Tilray (TLRY)?
